Can we develop pathology-specific MRI contrast for "MR-negative" epilepsy?

Kirk W Feindel1

  • 1School of Biomedical Engineering & Department of Radiology, Dalhousie University, Halifax, Nova Scotia, Canada. kirk.feindel@dal.ca

Epilepsia
|May 8, 2013
PubMed

Insights

Advanced magnetic resonance imaging (MRI) techniques like diffusional kurtosis imaging (DKI) and chemical exchange saturation transfer (CEST) offer new ways to detect epilepsy causes missed by standard MRI scans.

Area of Science:

  • Medical Physics
  • Neuroimaging
  • Epileptology

Background:

  • Standard MRI struggles to identify epilepsy causes due to reliance on bulk tissue properties.
  • Improvements in MRI hardware and software are reducing but not eliminating "MR-negative" epilepsy cases.

Purpose of the Study:

  • To review novel MR physics techniques for improved epilepsy diagnosis.
  • To explore the potential of advanced MRI methods in identifying pathologies in "MR-negative" epilepsy.

Main Methods:

  • Discussion of advanced MRI techniques including diffusional kurtosis imaging (DKI), temporal diffusion spectroscopy, and chemical exchange saturation transfer (CEST).
  • Focus on how these methods characterize tissue substructure and biochemical processes beyond standard MRI contrasts (T1, T2, diffusion-weighted).

Main Results:

  • DKI and temporal diffusion spectroscopy offer insights into tissue microstructure.
  • CEST imaging targets specific biochemical processes relevant to epilepsy pathologies.

Conclusions:

  • Novel MR physics techniques show promise in improving the detection of epilepsy causes.
  • These advanced methods could significantly reduce the burden of "MR-negative" epilepsy by providing pathology-specific contrast.